Retrospective analysis reveals worse visual outcomes in diabetic retinopathy patients treated post-COVID, suggesting urgent care is needed.
Purpose: To examine the effects of the pandemic on the presentation and outcomes of patients with complications of proliferative diabetic retinopathy (PDR) treated with pars plana vitrectomy (PPV). Methods: A retrospective chart review of eyes of adult patients who underwent PPV for complications of PDR from March 20, 2018, to March 20, 2022, at 2 county-based safety-net hospitals. March 20, 2020, is the cutoff date separating the pre- and post-COVID periods. Eyes with repeat PPVs and/or eyes without 6 months of follow-up were excluded. The primary outcome was visual acuity (VA) at postoperative month 6. Results: During the pre- and post-COVID periods, 253 and 234 eyes, respectively, had PPVs for PDR and at least 6 months of follow-up. The mean time from evaluation to surgery increased by 18 days. Post-COVID, more eyes presented with tractional retinal detachment (167 eyes [48%] vs 139 eyes [35%]; P = .0009) and macula-involving detachment (91 eyes [26%] vs 77 eyes [19%]; P = .0024), and the mean ± standard error VA was worse at postoperative month 6 (logMAR 1.11 ± 0.05 vs 0.94 ± 0.05; P = .0132). Within 6 months, there was no difference in the incidence of postoperative complications. Conclusions: During the pandemic, patients had more severe PDR complications and delays in surgical care, associated with worse visual outcomes after PPV.
No takes yet. Share an insight, caveat, or question.
Song et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: